149 related articles for article (PubMed ID: 20236350)
1. Predictability of future attacks by migraineurs: a prospective observational study.
Hu XH; Golden W; Bolge SC; Katic B; Chen YT; Wagner S; Cady R
Headache; 2010 Sep; 50(8):1296-305. PubMed ID: 20236350
[TBL] [Abstract][Full Text] [Related]
2. Depression and anxiety: effect on the migraine-obesity relationship.
Tietjen GE; Peterlin BL; Brandes JL; Hafeez F; Hutchinson S; Martin VT; Dafer RM; Aurora SK; Stein MR; Herial NA; Utley C; White L; Khuder SA
Headache; 2007 Jun; 47(6):866-75. PubMed ID: 17578537
[TBL] [Abstract][Full Text] [Related]
3. Recognition and therapeutic management of migraine in 2004, in France: results of FRAMIG 3, a French nationwide population-based survey.
Lucas C; Géraud G; Valade D; Chautard MH; Lantéri-Minet M
Headache; 2006 May; 46(5):715-25. PubMed ID: 16643573
[TBL] [Abstract][Full Text] [Related]
4. Predictors of adherence to triptans: factors of sustained vs lapsed users.
Cady RK; Maizels M; Reeves DL; Levinson DM; Evans JK
Headache; 2009 Mar; 49(3):386-94. PubMed ID: 19220501
[TBL] [Abstract][Full Text] [Related]
5. Treating early versus treating mild: timing of migraine prescription medications among patients with diagnosed migraine.
Foley KA; Cady R; Martin V; Adelman J; Diamond M; Bell CF; Dayno JM; Hu XH
Headache; 2005 May; 45(5):538-45. PubMed ID: 15953272
[TBL] [Abstract][Full Text] [Related]
6. Underdiagnosis and undertreatment of migraine in Italy: a survey of patients attending for the first time 10 headache centres.
Cevoli S; D'Amico D; Martelletti P; Valguarnera F; Del Bene E; De Simone R; Sarchielli P; Narbone M; Testa L; Genco S; Bussone G; Cortelli P
Cephalalgia; 2009 Dec; 29(12):1285-93. PubMed ID: 19438916
[TBL] [Abstract][Full Text] [Related]
7. Attitudes and burden of disease among self-considered migraineurs--a nation-wide population-based survey in Sweden.
Linde M; Dahlöf C
Cephalalgia; 2004 Jun; 24(6):455-65. PubMed ID: 15154855
[TBL] [Abstract][Full Text] [Related]
8. Can migraineurs accurately identify their headaches as "migraine" at attack onset?
Ng-Mak DS; Cady R; Chen YT; Ma L; Bell CF; Hu XH
Headache; 2007 May; 47(5):645-53. PubMed ID: 17501845
[TBL] [Abstract][Full Text] [Related]
9. Impact of migraine on patients and their families: the Migraine And Zolmitriptan Evaluation (MAZE) survey--Phase III.
MacGregor EA; Brandes J; Eikermann A; Giammarco R
Curr Med Res Opin; 2004 Jul; 20(7):1143-50. PubMed ID: 15265259
[TBL] [Abstract][Full Text] [Related]
10. The migraine cycle: patient burden of migraine during and between migraine attacks.
Brandes JL
Headache; 2008 Mar; 48(3):430-41. PubMed ID: 18179565
[TBL] [Abstract][Full Text] [Related]
11. Clinical characteristics and patterns of medication use of migraneurs in Latin America from 12 cities in 6 countries.
Morillo LE; Alarcon F; Aranaga N; Aulet S; Chapman E; Conterno L; Estevez E; Garcia-Pedroza F; Garrido J; Macias-Islas M; Monzillo P; Nunez L; Plascencia N; Rodriguez C; Takeuchi Y;
Headache; 2005 Feb; 45(2):118-26. PubMed ID: 15705116
[TBL] [Abstract][Full Text] [Related]
12. MIDAS and HIT-6 French translation: reliability and correlation between tests.
Magnoux E; Freeman MA; Zlotnik G
Cephalalgia; 2008 Jan; 28(1):26-34. PubMed ID: 17970768
[TBL] [Abstract][Full Text] [Related]
13. Satisfaction with and confidence in needle-free subcutaneous sumatriptan in patients currently treated with triptans.
Cady RK; Aurora SK; Brandes JL; Rothrock JF; Myers JA; Fox AW; Farr SJ
Headache; 2011 Sep; 51(8):1202-11. PubMed ID: 21812775
[TBL] [Abstract][Full Text] [Related]
14. Need for care and perceptions of MIDAS among headache sufferers study.
Stewart W; Lipton R
CNS Drugs; 2002; 16 Suppl 1():5-11. PubMed ID: 12196034
[TBL] [Abstract][Full Text] [Related]
15. Time to pain freedom and onset of pain relief with rizatriptan 10 mg and prescription usual-care oral medications in the acute treatment of migraine headaches: a multicenter, prospective, open-label, two-attack, crossover study.
Bell CF; Foley KA; Barlas S; Solomon G; Hu XH
Clin Ther; 2006 Jun; 28(6):872-80. PubMed ID: 16860170
[TBL] [Abstract][Full Text] [Related]
16. Allodynia in migraine: association with comorbid pain conditions.
Tietjen GE; Brandes JL; Peterlin BL; Eloff A; Dafer RM; Stein MR; Drexler E; Martin VT; Hutchinson S; Aurora SK; Recober A; Herial NA; Utley C; White L; Khuder SA
Headache; 2009 Oct; 49(9):1333-44. PubMed ID: 19788473
[TBL] [Abstract][Full Text] [Related]
17. Patterns of diagnosis and acute and preventive treatment for migraine in the United States: results from the American Migraine Prevalence and Prevention study.
Diamond S; Bigal ME; Silberstein S; Loder E; Reed M; Lipton RB
Headache; 2007 Mar; 47(3):355-63. PubMed ID: 17371352
[TBL] [Abstract][Full Text] [Related]
18. Effect of early intervention with almotriptan vs placebo on migraine-associated functional disability: results from the AEGIS Trial.
Freitag F; Smith T; Mathew N; Rupnow M; Greenberg S; Mao L; Finlayson G; Wright P; Biondi D;
Headache; 2008 Mar; 48(3):341-54. PubMed ID: 18302700
[TBL] [Abstract][Full Text] [Related]
19. Assessment of migraine severity using the MIGSEV scale: relationship to migraine features and quality of life.
El Hasnaoui A; Vray M; Blin P; Nachit-Ouinekh F; Boureau F;
Cephalalgia; 2004 Apr; 24(4):262-70. PubMed ID: 15030534
[TBL] [Abstract][Full Text] [Related]
20. Headache impact of chronic and episodic migraine: results from the American Migraine Prevalence and Prevention study.
Buse D; Manack A; Serrano D; Reed M; Varon S; Turkel C; Lipton R
Headache; 2012 Jan; 52(1):3-17. PubMed ID: 22106869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
